Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-309-6 | CAS number: 24549-06-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The oral LD50 for rats of 2-methyl-6-ethylaniline in these acute oral toxicity studies is found within 885 to 1700 mg/kg body weight.
The LC50 for 2-methyl-6-ethylaniline is 2.6 mg/l/ 4 h in air.
The dermal LD50 is 1290 mg/kg bw in rabbits.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 885 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 2 600 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 1 290 mg/kg bw
Additional information
Acute toxicity: oral
The oral toxicity of 2-methyl-6-ethylaniline (MEA) was evaluated in several studies with rats, mice or rabbits. All these studies show restrictions and deficiencies, but are appropriate for a weight of evidence approach. In a study with male Sprague-Dawley rats an oral LD50 of 1180 mg/kg body weight was determined (Jacobson 1972, Durden 1973). In another study with male and female Sprague-Dawley rats a LD50 value of 1150 mg/kg body weight was calculated (ECB 2000). In a publication from Short et al. (1983) an oral LD50 of 885 mg/kg body weight for the rat was published. In addition, Vasilenko (1987) published an oral LD50 value of 1700 mg/kg body weight for the rat and an oral LD50 value of 930 mg/kg body weight for mice. For rabbits an LD50 of 700 mg/kg body weight was published (Vasilenko (1987).
The oral LD50 for 2-methyl-6-ethylaniline as administered in these studies is found within 885 to 1700 mg/kg body weight.
In a special study with male Wistar rats the methemoglobin content was determinate after a single oral application of 2 -methyl-6-ethylaniline (MEA). The methemoglobin was determinate before and 1, 3, 7 and 24 hours post application. No relevant increase in methemoglobin was found in any of the dose groups evaluated. Clinical signs were observed after a single application of 500 mg/kg bw MEA. An increased oral discharge, rough fur, difficulties in breathing, cyanosis and poor general conditions were seen. The clinical signs developed 15 minutes after the application and continued up to 2 days. After 3 days no clinical signs were found anymore; one rat (1/5) of the highest dose group diet after 24 hours after the application. No clinical signs were seen in the 20 mg/kg bw and 100 mg/kg bw dose group. The body weight gain was not affected in any dose group evaluated. The pathological evaluation showed, that one rat (1/5) from the 20 mg/kg bw group had a slightly red mucous membrane of the small intestine. The animals from the 100 mg/kg bw and the 500 mg/kg bw dose group had a red mucous membrane of the small intestine and a change of the liver color (Bomhard 1989).
Acute toxicity: inhalation
The test substance 2 -methyl-6-ethylaniline (MEA) was evaluated in an acute inhalation study (Bechtel 1989). In this study three groups of 5 male and 5 female Sprague-Dawley rats were each exposed for 4 hours to an atmosphere of aerosolized 2-methyl-6-ethylaniline at mean analytical concentrations of 2.1, 2.5, or 3.2 mg per liter in air (whole body exposure). Exposure was followed by a 14-day observation period and subsequent necropsy. At the highest exposure concentration eight rats died, at the 2.5 mg/l level four animals died and at the 2.1 mg/l level two animals died. The calculated LC50 values for both sexes were 2.6 mg/l, for females 2.2 mg/l. and for the males 3.1 mg/l. The observations during exposure showed a visible hypo-activity of the animals and clear nasal discharge. The clinical signs noted immediately after exposure were non-responsiveness, disuse of limbs, labored respiration, clear nasal discharge, and salivation. The observations made during post-exposure day one and four showed non-responsiveness, prostrate, disuse of limbs, respiration difficulties, and ocular opacity. From post-exposure days 5 to 14 the only clinical sign noted was ocular opacity. There was weight loss in all animals by post-exposure day 2. By post-exposure day 14 all animals were gained weight and exceeded their pre-exposure weights. Gross necropsy findings noted in unscheduled deaths were corneal opacity, abnormal discharge/encrustation about eyes, abnormal liver color, fecal stained skin, abnormal color of testis, abnormal contents of urinary bladder. The only necropsy findings noted at the scheduled sacrifices were corneal opacity and hydronephrosis, which is relative common in animals of this strain and age and was not considered test-related.
The LC50 for 2-methyl-6-ethylaniline as administered in this study is 2.6 mg/l/ 4 h in air. As the animals were exposed whole-body there is a potential that dermal penetration added to the overall toxicity. Nevertheless, according to the findings of this study MEA should be classified as harmful by inhalation based on the classification criteria 67/548/EWG and regulation no. 1272/2008 (GHS).
Acute toxicity: dermal
A study with limited documentation and therefore low reliability revealed a LD50 dermal of 1290 mg/kg bw in rabbits (ECB 2000, secondary literature). This is in line with the available data on acute oral toxicity and reflects the good dermal resorption of MEA. In conclusion, MEA should be classified as harmful in contact with skin according to the classification criteria 67/548/EWG and regulation no. 1272/2008 (GHS).
Justification for classification or non-classification
According to the findings of the oral acute toxicity studies, the acute inhalation study and the data from the acute dermal toxicity study, MEA should be classified as harmful based on the classification criteria 67/548/EWG and regulation no.1272/2008 (GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.